BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 28467313)

  • 1. IgG,kappa monoclonal gammopathy of unknown significance with AL amyloidosis simulating giant cell arteritis.
    Pompilian VM; Tănăseanu Ş; Badea C; Zurac S; Socoliuc C; Badelita S; Botez E; Antohe M
    Rom J Intern Med; 2017 Sep; 55(3):179-182. PubMed ID: 28467313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular manifestation of giant cell arteritis vs AL-amyloidosis: similar presentations but different approaches.
    Azarfar A; Sharma A; Parikh JG; Shaikh NM; King-Morris K
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):117-122. PubMed ID: 32787554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A systemic disease mimicking a rheumatoid arthritis].
    Legrand M; Nouvier M; Paulin L; Deschamps B; Pialat JB; Coury F
    Rev Med Interne; 2019 Dec; 40(12):831-836. PubMed ID: 31444022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Light-chain amyloidosis mimicking giant cell arteritis in a bilateral anterior ischemic optic neuropathy case.
    Neri A; Rubino P; Macaluso C; Gandolfi SA
    BMC Ophthalmol; 2013 Dec; 13():82. PubMed ID: 24359546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal artery involvement in AL amyloidosis: an important differential diagnosis for giant cell arteritis. A case report and literature review.
    Oiwa H; Katoh N; Kojo S; Yoshinaga T; Taniguchi K; Shiote Y
    Mod Rheumatol Case Rep; 2020 Jan; 4(1):90-94. PubMed ID: 33086955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AL amyloidosis with temporal artery involvement simulates giant-cell arteritis.
    Audemard A; Boutemy J; Galateau-Salle F; Macro M; Bienvenu B
    Joint Bone Spine; 2012 Mar; 79(2):195-7. PubMed ID: 22209315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [More than 10 years of complete remission of monoclonal gammopathy of undetermined significance and cessation of light chain deposition disease-associated nephrotic syndrome following treatment with vincristine, adriamycin and high-dose dexamethasone (VAD)].
    Adam Z; Nedbálková M; Krejcí M; Pour L; Husek K; Veselý K; Cermáková Z; Krivanová A; Mayer J; Hájek R
    Vnitr Lek; 2010 Mar; 56(3):240-6. PubMed ID: 20394211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AA amyloidosis complicating monoclonal gammopathies, an unusual feature validating the concept of "monoclonal gammopathy of inflammatory significance"?
    Terré A; Colombat M; Cez A; Martin C; Diet C; Brechignac S; Oghina S; Bodez D; Faguer S; Savey L; Galland J; Boffa JJ; Grateau G; Jaccard A; Buob D; Georgin-Lavialle S
    Int J Clin Pract; 2021 Nov; 75(11):e14817. PubMed ID: 34490695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of Light Chain Proximal Tubulopathy without Crystals in IgGλ-type Monoclonal Gammopathy of Undetermined Significance Using Bortezomib and Dexamethasone.
    Tsuyuki T; Uramatsu T; Shimizu M; Ishi T; Tsuji K; Nakashima J; Katafuchi E; Nakayama T; Uesugi N; Muta K; Nishino T
    Intern Med; 2024 Mar; 63(5):693-698. PubMed ID: 37438138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse Peritoneal and Bowel Wall Infiltration by Light Chain-AL Amyloidosis with Omental Calcification Mimicking Abdominal Carcinomatosis - An Elderly Female with Incidental Finding of Light Chain Monoclonal Gammopathy of Undetermined Significance (LC-MGUS).
    Junejo S; Ali Y; Singh Lubana S; Tuli SS
    Am J Case Rep; 2017 Nov; 18():1247-1250. PubMed ID: 29176541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An unusual presentation of Amyloidosis AL].
    Zito A; De Pascalis A; Ria P; Armeni A; D'Amelio A; Napoli M
    G Ital Nefrol; 2018 May; 35(3):. PubMed ID: 29786185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal artery involvement revealing AL amyloidosis and IgD monoclonal gammopathy.
    Rodon P; Friocourt P; Blanchet S; Levallois D
    J Rheumatol; 1996 Jan; 23(1):189-90. PubMed ID: 8838533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
    Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
    Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [AL amyloidosis presenting with fluminant multiorgan failure accompanied by rapid progression from MGUS to multiple myeloma].
    Tazoe K; Takakuwa T; Makuuchi Y; Kuno M; Harada N; Okamura H; Nishimoto M; Koh H; Nakashima Y; Nakamae H; Hino M
    Rinsho Ketsueki; 2022; 63(1):31-36. PubMed ID: 35135949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal gammopathy of renal significance (MGRS)-related AL amyloidosis complicated by amyloid myopathy: a case report.
    Ono E; Ishii A; Higashi Y; Koita N; Ayaki T; Tanigaki K; Takayanagi S; Kondo N; Sakai K; Endo S; Yokoi H; Matsubara T; Minamiguchi S; Nishino I; Takahashi R; Yanagita M
    BMC Nephrol; 2021 Feb; 22(1):74. PubMed ID: 33639890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [IgG kappa monoclonal gammopathy complicated by AL amyloidosis with symptomatic involvement of the temporal artery].
    Nguyen TB; Auroy S; Baviera E; Galezowski N
    Rev Med Interne; 1996; 17(6):502. PubMed ID: 8758544
    [No Abstract]   [Full Text] [Related]  

  • 17. [Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance mimicking POEMS syndrome].
    Kanamori T; Kusumoto S; Okita K; Hagiwara S; Kato C; Nakashima T; Murakami S; Narita T; Ito A; Ri M; Ishida T; Komatsu H; Matsukawa N; Iida S
    Rinsho Ketsueki; 2018; 59(2):161-166. PubMed ID: 29515067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibronectin glomerulopathy with monoclonal gammopathy responding to bortezomib plus dexamethasone: a case report.
    Li X; Qi X; Ma Z; Huang W
    BMC Nephrol; 2022 Nov; 23(1):382. PubMed ID: 36451151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin-free light chain monomer-dimer patterns help to distinguish malignant from premalignant monoclonal gammopathies: a pilot study.
    Kaplan B; Golderman S; Aizenbud B; Esev K; Kukuy O; Leiba M; Livneh A; Ben-Zvi I
    Am J Hematol; 2014 Sep; 89(9):882-8. PubMed ID: 24866208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive chorioretinal involvement in a patient with light-chain (AL) amyloidosis: a case report.
    Augstburger E; Sahel JA; Audo I
    BMC Ophthalmol; 2020 Feb; 20(1):59. PubMed ID: 32085748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.